A Dose-finding and Confirmatory Trial of OPC-6535 in Patients With Active Crohn's Disease

NCT00989573 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

191

Enrollment

INDUSTRY

Sponsor class

Conditions

Crohn's Disease

Interventions

DRUG: Placebo
DRUG: OPC-6535
DRUG: OPC-6535

Sponsor

Otsuka Pharmaceutical Co., Ltd.